Evidence map›Paper›PMID 36188464›Full record

ArticleFrontiers in neuroscience2022

Zeping Xu, Jinjing Zhang, Junnan Wu, Shizhuo Yang, Yuying Li, Yuyu Wu, Siyuan Li, Xie Zhang, Wei Zuo, Xiang Lian and 5 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. International journal of molecular sciences · 2024
    Pooled it
  2. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Aging · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zeping XuDepartment of Pharmacy, Ningbo Medical Center Li Huili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, China.
Jinjing ZhangDepartment of Pharmacy, Affiliated Cixi Hospital, Wenzhou Medical University, Wenzhou, China.
Junnan WuSchool of Mental Health, Wenzhou Medical University, Wenzhou, China.
Shizhuo YangSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Yuying LiSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Yuyu WuSchool of Mental Health, Wenzhou Medical University, Wenzhou, China.
Siyuan LiSchool of Mental Health, Wenzhou Medical University, Wenzhou, China.
Xie ZhangDepartment of Pharmacy, Ningbo Medical Center Li Huili Hospital, The Affiliated Hospital of Ningbo University, Ningbo, China.
Wei ZuoThe Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China.
Xiang LianThe Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China.
Jianjun LinThe Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China.
Yongsheng JiangThe Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China.
Longteng XieThe Affiliated Xiangshan Hospital of Wenzhou Medical University, Ningbo, China.
Yanlong LiuSchool of Mental Health, Wenzhou Medical University, Wenzhou, China.
Ping WangThe Affiliated Kangning Hospital, Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long-term alcohol exposure is associated with oxidative stress, endoplasmic reticulum (ER) stress, and neuroinflammation, which may impair cognitive function. Probiotics supplements can significantly improve cognitive function in neurodegenerative diseases such as Alzheimer's disease. Nevertheless, the effect of Methods: A mouse model of cognitive dysfunction was established by intraperitoneal injection of alcohol (2 g/kg body weight) for 28 days. Mice were pre-treated with LP-cs, and cognitive function was evaluated using the Morris water maze test. Hippocampal tissues were collected for biochemical and molecular analysis. Results: LP-cs significantly ameliorated alcohol-induced decline in learning and memory function and hippocampal morphology changes, neuronal apoptosis, and synaptic dysfunction. A mechanistic study showed that alcohol activated protein kinase R-like endoplasmic reticulum kinase (PERK) signaling and suppressed brain derived neurotrophic factor (BDNF) levels via ER stress in the hippocampus, which LP-cs reversed. Alcohol activated oxidative stress and inflammation responses in the hippocampus, which LP-cs reversed. Conclusion: LP-cs significantly ameliorated alcohol-induced cognitive dysfunction and cellular stress. LP-cs might serve as an effective treatment for alcohol-induced cognitive dysfunction.

Indexed as

alcoholBDNFcognitive dysfunctionLactobacillus plantarum culture supernatantPERK

Identifiers

PMID36188464
PMCPMC9515438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.